Trial Title:
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
NCT ID:
NCT05675410
Condition:
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Conditions: Official terms:
Lymphoma
Hodgkin Disease
Deoxyglucose
Prednisone
Prednisolone
Methylprednisolone Acetate
Methylprednisolone
Methylprednisolone Hemisuccinate
Prednisolone acetate
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate
Hydrocortisone hemisuccinate
Cortisone
Cyclophosphamide
Dacarbazine
Doxorubicin
Liposomal doxorubicin
Nivolumab
Etoposide
Etoposide phosphate
Vincristine
Brentuximab Vedotin
Bleomycin
Vinblastine
Podophyllotoxin
Procarbazine
Antineoplastic Agents, Immunological
Antibodies
Immunoglobulins
Antibodies, Monoclonal
Imidazole
Prednisolone hemisuccinate
Prednisolone phosphate
Fluorodeoxyglucose F18
Immunoconjugates
Study type:
Interventional
Study phase:
Phase 3
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Sequential Assignment
Primary purpose:
Treatment
Masking:
None (Open Label)
Intervention:
Intervention type:
Procedure
Intervention name:
Biospecimen Collection
Description:
Undergo blood sample collection
Arm group label:
Arm A (ABVD)
Arm group label:
Arm B (ABVD, brentuximab vedotin, nivolumab)
Arm group label:
Arm C (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm D (ABVD, brentuximab vedotin, nivolumab, ISRT)
Arm group label:
Arm E (ABVD, AVD)
Arm group label:
Arm F (ABVD, brentuximab vedotin, nivolumab)
Arm group label:
Arm G (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm H (ABVD, brentuximab vedotin, nivolumab, ISRT)
Other name:
Biological Sample Collection
Other name:
Biospecimen Collected
Other name:
Specimen Collection
Intervention type:
Biological
Intervention name:
Bleomycin Sulfate
Description:
Given IV
Arm group label:
Arm A (ABVD)
Arm group label:
Arm B (ABVD, brentuximab vedotin, nivolumab)
Arm group label:
Arm C (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm D (ABVD, brentuximab vedotin, nivolumab, ISRT)
Arm group label:
Arm E (ABVD, AVD)
Arm group label:
Arm F (ABVD, brentuximab vedotin, nivolumab)
Arm group label:
Arm G (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm H (ABVD, brentuximab vedotin, nivolumab, ISRT)
Other name:
Blanoxan
Other name:
BleMomycine
Other name:
Blenoxane
Other name:
Bleo-cell
Other name:
Bleo-S
Other name:
Bleocin
Other name:
Bleolem
Other name:
Bleomycin Sulfas
Other name:
Bleomycin Sulphate
Other name:
Bleomycini Sulfas
Other name:
Blexane
Other name:
Oil Bleo
Intervention type:
Drug
Intervention name:
Brentuximab Vedotin
Description:
Given IV
Arm group label:
Arm B (ABVD, brentuximab vedotin, nivolumab)
Arm group label:
Arm D (ABVD, brentuximab vedotin, nivolumab, ISRT)
Arm group label:
Arm F (ABVD, brentuximab vedotin, nivolumab)
Arm group label:
Arm H (ABVD, brentuximab vedotin, nivolumab, ISRT)
Other name:
ADC SGN-35
Other name:
Adcetris
Other name:
Anti-CD30 Antibody-Drug Conjugate SGN-35
Other name:
Anti-CD30 Monoclonal Antibody-MMAE SGN-35
Other name:
Anti-CD30 Monoclonal Antibody-Monomethylauristatin E SGN-35
Other name:
cAC10-vcMMAE
Other name:
SGN 35
Other name:
SGN-35
Other name:
SGN35
Intervention type:
Procedure
Intervention name:
Computed Tomography
Description:
Undergo CT and/or PET-CT
Arm group label:
Arm A (ABVD)
Arm group label:
Arm B (ABVD, brentuximab vedotin, nivolumab)
Arm group label:
Arm C (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm D (ABVD, brentuximab vedotin, nivolumab, ISRT)
Arm group label:
Arm E (ABVD, AVD)
Arm group label:
Arm F (ABVD, brentuximab vedotin, nivolumab)
Arm group label:
Arm G (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm H (ABVD, brentuximab vedotin, nivolumab, ISRT)
Other name:
CAT
Other name:
CAT Scan
Other name:
Computed Axial Tomography
Other name:
Computerized Axial Tomography
Other name:
Computerized axial tomography (procedure)
Other name:
Computerized Tomography
Other name:
Computerized Tomography (CT) scan
Other name:
CT
Other name:
CT Scan
Other name:
tomography
Intervention type:
Drug
Intervention name:
Cyclophosphamide
Description:
Given IV
Arm group label:
Arm C (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm G (ABVD, eBEACOPP, ISRT)
Other name:
(-)-Cyclophosphamide
Other name:
2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate
Other name:
Asta B 518
Other name:
B 518
Other name:
B-518
Other name:
B518
Other name:
Carloxan
Other name:
Ciclofosfamida
Other name:
Ciclofosfamide
Other name:
Cicloxal
Other name:
Clafen
Other name:
Claphene
Other name:
CP monohydrate
Other name:
CTX
Other name:
CYCLO-cell
Other name:
Cycloblastin
Other name:
Cycloblastine
Other name:
Cyclophospham
Other name:
Cyclophosphamid monohydrate
Other name:
Cyclophosphamide Monohydrate
Other name:
Cyclophosphamidum
Other name:
Cyclophosphan
Other name:
Cyclophosphane
Other name:
Cyclophosphanum
Other name:
Cyclostin
Other name:
Cyclostine
Other name:
Cytophosphan
Other name:
Cytophosphane
Other name:
Cytoxan
Other name:
Fosfaseron
Other name:
Genoxal
Other name:
Genuxal
Other name:
Ledoxina
Other name:
Mitoxan
Other name:
Neosar
Other name:
Revimmune
Other name:
Syklofosfamid
Other name:
WR 138719
Other name:
WR- 138719
Other name:
WR-138719
Other name:
WR138719
Intervention type:
Drug
Intervention name:
Dacarbazine
Description:
Given IV
Arm group label:
Arm A (ABVD)
Arm group label:
Arm B (ABVD, brentuximab vedotin, nivolumab)
Arm group label:
Arm C (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm D (ABVD, brentuximab vedotin, nivolumab, ISRT)
Arm group label:
Arm E (ABVD, AVD)
Arm group label:
Arm F (ABVD, brentuximab vedotin, nivolumab)
Arm group label:
Arm G (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm H (ABVD, brentuximab vedotin, nivolumab, ISRT)
Other name:
4-(Dimethyltriazeno)imidazole-5-carboxamide
Other name:
5-(Dimethyltriazeno)imidazole-4-carboxamide
Other name:
Asercit
Other name:
Biocarbazine
Other name:
Dacarbazina
Other name:
Dacarbazina Almirall
Other name:
Dacarbazine - DTIC
Other name:
Dacatic
Other name:
Dakarbazin
Other name:
Deticene
Other name:
Detimedac
Other name:
DIC
Other name:
Dimethyl (triazeno) imidazolecarboxamide
Other name:
Dimethyl Triazeno Imidazol Carboxamide
Other name:
Dimethyl Triazeno Imidazole Carboxamide
Other name:
dimethyl-triazeno-imidazole carboxamide
Other name:
Dimethyl-triazeno-imidazole-carboximide
Other name:
DTIC
Other name:
DTIC-Dome
Other name:
Fauldetic
Other name:
Imidazole Carboxamide
Other name:
Imidazole Carboxamide Dimethyltriazeno
Other name:
WR-139007
Intervention type:
Drug
Intervention name:
Doxorubicin Hydrochloride
Description:
Given IV
Arm group label:
Arm A (ABVD)
Arm group label:
Arm B (ABVD, brentuximab vedotin, nivolumab)
Arm group label:
Arm C (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm D (ABVD, brentuximab vedotin, nivolumab, ISRT)
Arm group label:
Arm E (ABVD, AVD)
Arm group label:
Arm F (ABVD, brentuximab vedotin, nivolumab)
Arm group label:
Arm G (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm H (ABVD, brentuximab vedotin, nivolumab, ISRT)
Other name:
5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- (9CI)
Other name:
ADM
Other name:
Adriacin
Other name:
Adriamycin
Other name:
Adriamycin Hydrochloride
Other name:
Adriamycin PFS
Other name:
Adriamycin RDF
Other name:
ADRIAMYCIN, HYDROCHLORIDE
Other name:
Adriamycine
Other name:
Adriblastina
Other name:
Adriblastine
Other name:
Adrimedac
Other name:
Chloridrato de Doxorrubicina
Other name:
DOX
Other name:
DOXO-CELL
Other name:
Doxolem
Other name:
Doxorubicin HCl
Other name:
Doxorubicin.HCl
Other name:
Doxorubin
Other name:
Farmiblastina
Other name:
FI 106
Other name:
FI-106
Other name:
FI106
Other name:
hydroxydaunorubicin
Other name:
Rubex
Intervention type:
Drug
Intervention name:
Etoposide
Description:
Given IV
Arm group label:
Arm C (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm G (ABVD, eBEACOPP, ISRT)
Other name:
Demethyl Epipodophyllotoxin Ethylidine Glucoside
Other name:
EPEG
Other name:
Lastet
Other name:
Toposar
Other name:
Vepesid
Other name:
VP 16
Other name:
VP 16-213
Other name:
VP 16213
Other name:
VP-16
Other name:
VP-16-213
Other name:
VP-16213
Other name:
VP16
Other name:
VP16213
Intervention type:
Drug
Intervention name:
Etoposide Phosphate
Description:
Given IV
Arm group label:
Arm C (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm G (ABVD, eBEACOPP, ISRT)
Other name:
Etopophos
Intervention type:
Other
Intervention name:
Fludeoxyglucose F-18
Description:
Undergo FDG-PET
Arm group label:
Arm A (ABVD)
Arm group label:
Arm B (ABVD, brentuximab vedotin, nivolumab)
Arm group label:
Arm C (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm D (ABVD, brentuximab vedotin, nivolumab, ISRT)
Arm group label:
Arm E (ABVD, AVD)
Arm group label:
Arm F (ABVD, brentuximab vedotin, nivolumab)
Arm group label:
Arm G (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm H (ABVD, brentuximab vedotin, nivolumab, ISRT)
Other name:
18FDG
Other name:
FDG
Other name:
Fludeoxyglucose (18F)
Other name:
fludeoxyglucose F 18
Other name:
Fludeoxyglucose F18
Other name:
Fluorine-18 2-Fluoro-2-deoxy-D-Glucose
Other name:
Fluorodeoxyglucose F18
Intervention type:
Radiation
Intervention name:
Involved-site Radiation Therapy
Description:
Undergo ISRT
Arm group label:
Arm C (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm D (ABVD, brentuximab vedotin, nivolumab, ISRT)
Arm group label:
Arm G (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm H (ABVD, brentuximab vedotin, nivolumab, ISRT)
Other name:
ISRT
Intervention type:
Procedure
Intervention name:
Magnetic Resonance Imaging
Description:
Undergo MRI and/or PET-MRI
Arm group label:
Arm A (ABVD)
Arm group label:
Arm B (ABVD, brentuximab vedotin, nivolumab)
Arm group label:
Arm C (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm D (ABVD, brentuximab vedotin, nivolumab, ISRT)
Arm group label:
Arm E (ABVD, AVD)
Arm group label:
Arm F (ABVD, brentuximab vedotin, nivolumab)
Arm group label:
Arm G (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm H (ABVD, brentuximab vedotin, nivolumab, ISRT)
Other name:
Magnetic Resonance
Other name:
Magnetic Resonance Imaging (MRI)
Other name:
Magnetic resonance imaging (procedure)
Other name:
Magnetic Resonance Imaging Scan
Other name:
Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance
Other name:
MR
Other name:
MR Imaging
Other name:
MRI
Other name:
MRI Scan
Other name:
MRIs
Other name:
NMR Imaging
Other name:
NMRI
Other name:
Nuclear Magnetic Resonance Imaging
Other name:
sMRI
Other name:
Structural MRI
Intervention type:
Biological
Intervention name:
Nivolumab
Description:
Given IV
Arm group label:
Arm B (ABVD, brentuximab vedotin, nivolumab)
Arm group label:
Arm D (ABVD, brentuximab vedotin, nivolumab, ISRT)
Arm group label:
Arm F (ABVD, brentuximab vedotin, nivolumab)
Arm group label:
Arm H (ABVD, brentuximab vedotin, nivolumab, ISRT)
Other name:
ABP 206
Other name:
BCD-263
Other name:
BMS 936558
Other name:
BMS-936558
Other name:
BMS936558
Other name:
CMAB819
Other name:
MDX 1106
Other name:
MDX-1106
Other name:
MDX1106
Other name:
NIVO
Other name:
Nivolumab Biosimilar ABP 206
Other name:
Nivolumab Biosimilar BCD-263
Other name:
Nivolumab Biosimilar CMAB819
Other name:
ONO 4538
Other name:
ONO-4538
Other name:
ONO4538
Other name:
Opdivo
Intervention type:
Procedure
Intervention name:
Positron Emission Tomography
Description:
Undergo FDG-PET, PET, PET-CT, and/or PET-MRI
Arm group label:
Arm A (ABVD)
Arm group label:
Arm B (ABVD, brentuximab vedotin, nivolumab)
Arm group label:
Arm C (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm D (ABVD, brentuximab vedotin, nivolumab, ISRT)
Arm group label:
Arm E (ABVD, AVD)
Arm group label:
Arm F (ABVD, brentuximab vedotin, nivolumab)
Arm group label:
Arm G (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm H (ABVD, brentuximab vedotin, nivolumab, ISRT)
Other name:
Medical Imaging, Positron Emission Tomography
Other name:
PET
Other name:
PET Scan
Other name:
Positron emission tomography (procedure)
Other name:
Positron Emission Tomography Scan
Other name:
Positron-Emission Tomography
Other name:
proton magnetic resonance spectroscopic imaging
Other name:
PT
Intervention type:
Drug
Intervention name:
Prednisolone
Description:
Given PO
Arm group label:
Arm C (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm G (ABVD, eBEACOPP, ISRT)
Other name:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
Other name:
.delta.1-Hydrocortisone
Other name:
Adnisolone
Other name:
Aprednislon
Other name:
Capsoid
Other name:
Cortalone
Other name:
Cortisolone
Other name:
Dacortin H
Other name:
Decaprednil
Other name:
Decortin H
Other name:
Delta(1)Hydrocortisone
Other name:
Delta- Cortef
Other name:
Delta-Cortef
Other name:
Delta-Diona
Other name:
Delta-F
Other name:
Delta-Phoricol
Other name:
Delta1-dehydro-hydrocortisone
Other name:
Deltacortril
Other name:
Deltahydrocortisone
Other name:
Deltasolone
Other name:
Deltidrosol
Other name:
Dhasolone
Other name:
Di-Adreson-F
Other name:
Dontisolon D
Other name:
Estilsona
Other name:
Fisopred
Other name:
Frisolona
Other name:
Gupisone
Other name:
Hostacortin H
Other name:
Hydeltra
Other name:
Hydeltrasol
Other name:
Klismacort
Other name:
Kuhlprednon
Other name:
Lenisolone
Other name:
Lepi-Cortinolo
Other name:
Linola-H N
Other name:
Linola-H-Fett N
Other name:
Longiprednil
Other name:
Metacortandralone
Other name:
Meti Derm
Other name:
Meticortelone
Other name:
Opredsone
Other name:
Panafcortelone
Other name:
Precortisyl
Other name:
Pred-Clysma
Other name:
Predeltilone
Other name:
Predni-Coelin
Other name:
Predni-Helvacort
Other name:
Prednicortelone
Other name:
Prednisolonum
Other name:
Prelone
Other name:
Prenilone
Other name:
Sterane
Intervention type:
Drug
Intervention name:
Prednisone
Description:
Given PO
Arm group label:
Arm C (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm G (ABVD, eBEACOPP, ISRT)
Other name:
.delta.1-Cortisone
Other name:
1, 2-Dehydrocortisone
Other name:
Adasone
Other name:
Cortancyl
Other name:
Dacortin
Other name:
DeCortin
Other name:
Decortisyl
Other name:
Decorton
Other name:
Delta 1-Cortisone
Other name:
Delta-Dome
Other name:
Deltacortene
Other name:
Deltacortisone
Other name:
Deltadehydrocortisone
Other name:
Deltasone
Other name:
Deltison
Other name:
Deltra
Other name:
Econosone
Other name:
Lisacort
Other name:
Meprosona-F
Other name:
Metacortandracin
Other name:
Meticorten
Other name:
Ofisolona
Other name:
Orasone
Other name:
Panafcort
Other name:
Panasol-S
Other name:
Paracort
Other name:
Perrigo Prednisone
Other name:
PRED
Other name:
Predicor
Other name:
Predicorten
Other name:
Prednicen-M
Other name:
Prednicort
Other name:
Prednidib
Other name:
Prednilonga
Other name:
Predniment
Other name:
Prednisone Intensol
Other name:
Prednisonum
Other name:
Prednitone
Other name:
Promifen
Other name:
Rayos
Other name:
Servisone
Other name:
SK-Prednisone
Intervention type:
Drug
Intervention name:
Procarbazine Hydrochloride
Description:
Given PO
Arm group label:
Arm C (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm G (ABVD, eBEACOPP, ISRT)
Other name:
Benzamide, N-(1-methylethyl)-4-[(2-methylhydrazino) methyl]-, monohydrochloride (9CI)
Other name:
Ibenzmethyzine hydrochloride
Other name:
Matulane
Other name:
MIH hydrochloride
Other name:
Natulan
Other name:
Natulanar
Other name:
Natunalar
Other name:
NCI C01810
Other name:
NCI-C01810
Other name:
NCIC01810
Other name:
p-(N'-methylhydrazinomethyl)-N-isopropylbenzamide hydrochloride
Other name:
p-Toluamide, N-isopropyl-.alpha.-(2-methylhydrazino)-, monohydrochloride (8CI)
Other name:
PCB
Other name:
PCB Hydrochloride
Other name:
PCZ
Other name:
Ro 4 6467/1
Other name:
Ro 4-6467/1
Intervention type:
Other
Intervention name:
Questionnaire Administration
Description:
Ancillary studies
Arm group label:
Arm A (ABVD)
Arm group label:
Arm B (ABVD, brentuximab vedotin, nivolumab)
Arm group label:
Arm C (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm D (ABVD, brentuximab vedotin, nivolumab, ISRT)
Arm group label:
Arm E (ABVD, AVD)
Arm group label:
Arm F (ABVD, brentuximab vedotin, nivolumab)
Arm group label:
Arm G (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm H (ABVD, brentuximab vedotin, nivolumab, ISRT)
Intervention type:
Drug
Intervention name:
Vinblastine Sulfate
Description:
Given IV
Arm group label:
Arm A (ABVD)
Arm group label:
Arm B (ABVD, brentuximab vedotin, nivolumab)
Arm group label:
Arm C (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm D (ABVD, brentuximab vedotin, nivolumab, ISRT)
Arm group label:
Arm E (ABVD, AVD)
Arm group label:
Arm F (ABVD, brentuximab vedotin, nivolumab)
Arm group label:
Arm G (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm H (ABVD, brentuximab vedotin, nivolumab, ISRT)
Other name:
29060 LE
Other name:
29060-LE
Other name:
Exal
Other name:
Velban
Other name:
Velbe
Other name:
Velsar
Other name:
VINCALEUKOBLASTINE
Intervention type:
Drug
Intervention name:
Vincristine Sulfate
Description:
Given IV
Arm group label:
Arm C (ABVD, eBEACOPP, ISRT)
Arm group label:
Arm G (ABVD, eBEACOPP, ISRT)
Other name:
Kyocristine
Other name:
Leurocristine Sulfate
Other name:
Leurocristine, sulfate
Other name:
Oncovin
Other name:
Vincasar
Other name:
Vincosid
Other name:
Vincrex
Other name:
Vincristine, sulfate
Summary:
This phase III trial compares the effect of adding immunotherapy (brentuximab vedotin and
nivolumab) to standard treatment (chemotherapy with or without radiation) to the standard
treatment alone in improving survival in patients with stage I and II classical Hodgkin
lymphoma. Brentuximab vedotin is in a class of medications called antibody-drug
conjugates. It is made of a monoclonal antibody called brentuximab that is linked to a
cytotoxic agent called vedotin. Brentuximab attaches to CD30 positive lymphoma cells in a
targeted way and delivers vedotin to kill them. A monoclonal antibody is a type of
protein that can bind to certain targets in the body, such as molecules that cause the
body to make an immune response (antigens). Immunotherapy with monoclonal antibodies,
such as nivolumab, may help the body's immune system attack the cancer, and may interfere
with the ability of tumor cells to grow and spread. Chemotherapy drugs such as
doxorubicin hydrochloride, bleomycin sulfate, vinblastine sulfate, dacarbazine, and
procarbazine hydrochloride work in different ways to stop the growth of cancer cells,
either by killing the cells, by stopping them from dividing, or by stopping them from
spreading. Cyclophosphamide is in a class of medications called alkylating agents. It
works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It
may also lower the body's immune response. Etoposide is in a class of medications known
as podophyllotoxin derivatives. It blocks a certain enzyme needed for cell division and
DNA repair and may kill cancer cells. Vincristine is in a class of medications called
vinca alkaloids. It works by stopping cancer cells from growing and dividing and may kill
them. Prednisone is in a class of medications called corticosteroids. It is used to
reduce inflammation and lower the body's immune response to help lessen the side effects
of chemotherapy drugs. Radiation therapy uses high energy x-rays to kill tumor cells and
shrink tumors. Adding immunotherapy to the standard treatment of chemotherapy with or
without radiation may increase survival and/or fewer short-term or long-term side effects
in patients with classical Hodgkin lymphoma compared to the standard treatment alone.
Detailed description:
PRIMARY OBJECTIVES:
I. To compare the progression-free survival (PFS) of a standard chemotherapy approach
versus an immunotherapy (IO) approach (brentuximab vedotin and nivolumab) in patients
with newly diagnosed early stage classic Hodgkin lymphoma (cHL) who have a rapid early
response (RER) as determined by position emission tomography post cycle 2 (PET2) after 2
cycles of doxorubicin, bleomycin, vinblastine, dacarbazine (ABVD) chemotherapy.
II. To compare the PFS of a standard chemotherapy approach versus an IO therapy approach
(brentuximab vedotin and nivolumab) plus involved site radiation therapy (ISRT) in
patients with newly diagnosed early stage cHL who have a slow early response (SER) as
determined by PET2 after 2 cycles of ABVD chemotherapy.
SECONDARY OBJECTIVES:
I. To demonstrate non-inferiority of overall survival (OS) at 12 years of IO therapy
versus standard therapy in early stage cHL patients who have a RER as determined by PET2
after 2 cycles of doxorubicin, bleomycin, vinblastine, dacarbazine (ABVD) chemotherapy.
II. To evaluate the overall survival (OS) at 12 years of IO therapy versus standard
therapy in early stage cHL patients who have a SER as determined by PET2 after 2 cycles
of doxorubicin, bleomycin, vinblastine, dacarbazine (ABVD) chemotherapy.
III. To demonstrate non-inferiority of overall survival (OS) at 12 years of IO therapy
versus standard therapy in early stage cHL patients.
IV. To evaluate in patients with newly diagnosed early stage cHL the PFS of a standard
chemotherapy approach versus an IO therapy approach (brentuximab vedotin and nivolumab)
in the overall cohort, in the favorable risk cohort, and in the unfavorable risk cohort.
V. To evaluate the event-free survival (EFS) at 12 years of patients undergoing standard
chemotherapy versus an IO therapy approach (brentuximab vedotin and nivolumab).
VI. To compare the physician-reported treatment-related adverse event (AE) rates between
a standard chemotherapy approach and an IO therapy approach (brentuximab vedotin and
nivolumab) in patients with newly diagnosed early stage cHL.
VII. To compare patient-reported adverse events using pediatric and adult versions of
Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events
(PRO-CTCAE), stratified by age groups, therapeutic arms, and receipt of radiation therapy
(RT) over time.
VIII. To evaluate changes in patient-reported fatigue, cognitive functioning, and
health-related quality of life (HRQoL), e.g., emotional, physical, and role functioning,
by treatment arm, using validated adult and pediatric measurement systems.
IX. To evaluate self-reported late morbidities (e.g., cardiovascular, pulmonary and
endocrine) over time for children, adolescents and adults undergoing standard
chemotherapy versus an IO therapy approach (brentuximab vedotin and nivolumab) with and
without RT using measures from the St. Jude Lifetime Cohort Study (SJLIFE).
X. To evaluate fludeoxyglucose F-18 (FDG)-position emission tomography (PET) measurements
of metabolic tumor burden (MTV and total lesion glycolysis [TLG]) at PET at baseline
(PET1) as a predictive marker of PFS.
XI. To evaluate the associations between race/ethnicity and key outcomes including early
response to therapy, PFS and OS.
EXPLORATORY OBJECTIVES:
I. To evaluate the PFS of a standard chemotherapy approach versus an IO therapy approach
(brentuximab vedotin and nivolumab) in patients with newly diagnosed early stage cHL
across different age groups (ages 5-11 years, 12-21 years, 22-39 years, 40-60 years).
II. To bank specimens for future correlative studies. III. To assess concordance and
discordance of rapid central review and local institutional review of FDG PET 5-point
score (5-PS; previously referred to as Deauville score) at baseline PET1, interim PET2
and end of systemic therapy PET-end of systemic therapy (EST) SER.
IV. To assess the association between PFS and the quantitative FDG-PET/computed
tomography (CT) parameters (PET MTV, TLG, delta-standardized uptake value [SUV] and PET
SUV-based quantitative surrogates [qPET] of visual qualitative 5-PS) on measurements by
automated measurements using convolutional neural networks (CNNs) through
artificial-intelligence (AI) machine learning in the entire population.
V. To assess the agreement between quantitative FDG-PET/CT parameters obtained using AI
and those based on measurements by a trained imaging physician.
VI. To compare patient-reported adverse events (via pediatric [Ped]-PRO-CTCAE and
PRO-CTCAE) to provider adverse event reporting.
VII. To evaluate the association between self-reported race/ethnicity and social
determinants of health.
VIII. To evaluate the associations between race/ethnicity and
post-progression/post-relapse overall survival.
IX. To evaluate the completion rates of PRO and health-related quality of life (HRQoL)
contact forms at 1 year off treatment for the first 450 eligible patients.
X. To collect contact information from participants for future re-contact.
OUTLINE: Patients are stratified by risk status (favorable versus unfavorable) and then
all patients receive 2 cycles of ABVD regimen (doxorubicin hydrochloride intravenously
[IV], bleomycin sulfate IV, vinblastine sulfate IV, and dacarbazine IV) on days 1 and 15
of each treatment cycle. Each treatment cycle lasts 28 days. Patients then undergo early
response assessment and are randomized to 1 of 8 arms.
ARM A (RER, FAVORABLE): Patients receive ABVD IV for an additional 2 cycles on study.
Each cycle lasts 28 days and ABVD is administered on days 1 and 15 of each cycle.
Patients also undergo FDG-PET, PET, PET-CT, PET-MRI, CT, and/or magnetic resonance
imaging (MRI) throughout the trial. Patients may also undergo blood sample collection on
trial.
ARM B (RER, FAVORABLE): Patients receive brentuximab vedotin IV and nivolumab IV once
during each treatment cycle. Each cycle lasts 21 days. Treatment continues for 4 cycles.
Patients also undergo FDG-PET, PET, PET-CT, PET-MRI, CT, and/or MRI throughout the trial.
Patients may also undergo blood sample collection on trial.
ARM C (SER, FAVORABLE): Patients receive eBEACOPP regimen (doxorubicin hydrochloride IV
on day 1, cyclophosphamide IV on day 1, etoposide or etoposide phosphate IV on days 1-3,
prednisone or prednisolone orally [PO] daily for the first 14 days of each treatment
cycle, procarbazine hydrochloride PO on days 1-7, bleomycin sulfate IV on day 8, and
vincristine sulfate IV) on day 8 of each treatment cycle. Treatment continues for 2
cycles. Each cycle lasts 21 days. Subsequently, patients undergo ISRT. Patients also
undergo FDG-PET, PET, PET-CT, PET-MRI, CT, and/or MRI throughout the trial. Patients may
also undergo blood sample collection on trial.
ARM D (SER, FAVORABLE): Patients receive brentuximab vedotin IV and nivolumab IV as in
arm B followed by ISRT. Patients also undergo FDG-PET, PET, PET-CT, PET-MRI, CT, and/or
MRI throughout the trial. Patients may also undergo blood sample collection on trial.
ARM E (RER, UNFAVORABLE): Patients receive AVD regimen (doxorubicin hydrochloride IV,
vinblastine IV, and dacarbazine IV) on days 1 and 15 of each treatment cycle. Each cycle
lasts 28 days. Treatment continues for 4 cycles. Patients also undergo FDG-PET, PET,
PET-CT, PET-MRI, CT, and/or MRI throughout the trial. Patients may also undergo blood
sample collection on trial.
ARM F (RER, UNFAVORABLE): Patients receive treatment as in arm B. Patients also undergo
FDG-PET, PET, PET-CT, PET-MRI, CT, and/or MRI throughout the trial. Patients may also
undergo blood sample collection on trial.
ARM G (SER, UNFAVORABLE): Patients receive treatment and imaging, and may undergo blood
sample collection as in arm C.
ARM H (SER, UNFAVORABLE): Patients receive treatment and imaging, and may undergo blood
sample collection as in arm D.
After completion of study treatment, patients are followed up every 3 months for the
first year, then every 6 months for the second and third year, then annually until 12
years from date of registration.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Patients must be 5 to 60 years of age at the time of enrollment
- Patients with newly diagnosed untreated histologically confirmed classic Hodgkin
lymphoma (cHL) (nodular sclerosis, mixed cellularity, lymphocyte-rich, or
lymphocyte-depleted, or not otherwise specified [NOS]) with stage I or II disease
- Patients must have bidimensionally measurable disease (at least one lesion with
longest diameter >= 1.5 cm)
- Patients must have a whole body or limited whole body PET scan performed within 42
days prior to enrollment. PET-CT is strongly preferred. PET-MRI allowed if
intravenous contrast enhanced CT is also obtained
- Pediatric patients (age 5-17 years) must have an upright posteroanterior (PA) chest
X-ray (CXR) for assessment of bulky mediastinal disease. Adult patients must have
either a CXR or CT chest
- Patients >= 18 years must have a performance status corresponding to Zubrod scores
of 0, 1 or 2
- Patients =< 17 years of age must have a Lansky performance score of >= 50
- Pediatric patients (age 5-17 years): A serum creatinine based on age/gender as
follows (within 7 days prior to enrollment):
- 2 to < 6 years (age): 0.8 mg/dL (male), 0.8 mg/dL (female)
- 6 to < 10 years (age): 1 mg/dL (male), 1 mg/dL (female)
- 10 to < 13 years (age): 1.2 mg/dL (male), 1.2 mg/dL (female)
- 13 to < 16 years (age): 1.5 mg/dL (male), 1.4 mg/dL (female)
- >= 16 years (age): 1.7 mg/dL (male), 1.4 mg/dL (female) OR a 24 hour urine
creatinine clearance >= 50 mL/min/1.73 m^2 (within 7 days prior to enrollment)
OR a glomerular filtration rate (GFR) >= 50 mL/min/1.73 m^2 (within 7 days
prior to enrollment). GFR must be performed using direct measurement with a
nuclear blood sampling method OR direct small molecule clearance method
(iothalamate or other molecule per institutional standard)
- Note: Estimated GFR (eGFR) from serum or plasma creatinine, cystatin C or other
estimates are not acceptable for determining eligibility
- For adult patients (age 18 years or older) (within 7 days prior to enrollment):
Creatinine clearance >= 30 mL/min, as estimated by the Cockcroft and Gault formula
or a 24-hour urine collection. The creatinine value used in the calculation must
have been obtained within 28 days prior to registration. Estimated creatinine
clearance is based on actual body weight
- Total bilirubin =< 2 x upper limit of normal (ULN) (within 7 days prior to
enrollment)
- Unless due to Gilbert's disease, lymphomatous involvement of liver or vanishing
bile duct syndrome
- Aspartate aminotransferase (AST) =< 3 x ULN (within 7 days prior to enrollment)
- Unless due to Gilbert's disease, lymphomatous involvement of liver or vanishing
bile duct syndrome
- Alanine aminotransferase (ALT) =< 3 x ULN (within 7 days prior to enrollment)
- Unless due to Gilbert's disease, lymphomatous involvement of liver or vanishing
bile duct syndrome
- Shortening fraction of >= 27% by echocardiogram (ECHO), multigated acquisition scan
(MUGA), or functional cardiac imaging scan (within 7 days prior to enrollment) or
ejection fraction of >= 50% by radionuclide angiogram, ECHO, MUGA, or cardiac
imaging scan (within 7 days prior to enrollment)
- Diffusion capacity of the lung for carbon monoxide (DLCO) >= 50% of predicted value
as corrected for hemoglobin by pulmonary function test (PFT) (within 7 days prior to
enrollment). If unable to obtain PFTs, the criterion is: a pulse oximetry reading of
> 92% on room air
- Known human immunodeficiency virus (HIV)-infected patients on effective
anti-retroviral therapy with undetectable viral load within 6 months are eligible
for this trial
- For patients with evidence of chronic hepatitis B virus (HBV) infection, the HBV
viral load must be undetectable on suppressive therapy, if indicated. Patients with
a history of hepatitis C virus (HCV) infection must have been treated and cured. For
patients with HCV infection who are currently on treatment, they are eligible if
they have an undetectable HCV viral load
Exclusion Criteria:
- Patients with nodular lymphocyte predominant Hodgkin lymphoma
- Patients with a history of active interstitial pneumonitis or interstitial lung
disease
- Patients with a diagnosis of inherited or acquired immunodeficiency that is poorly
controlled or requiring active medications, such as primary immunodeficiency
syndromes or organ transplant recipients
- Patients with any known uncontrolled intercurrent illness that would jeopardize the
patient's safety such as infection, autoimmune conditions, cardiac arrhythmias,
angina pectoris, and gastrointestinal disorders affecting swallowing and/or
absorption of pills
- Patients with a condition requiring systemic treatment with either corticosteroids
(defined as equivalent to > 10 mg daily prednisone for patients >= 18 years or > 0.5
mg/kg [up to 10 mg/day] for patients < 18 years) or other immunosuppressive
medications within 14 days prior to enrollment
- Note: Replacement therapy such as thyroxine, insulin, or physiologic
corticosteroid for adrenal or pituitary insufficiency is not considered a form
of systemic treatment. Inhaled or topical steroids, and adrenal replacement
doses (=< 10 mg daily for patients >= 18 years or =< 0.5 mg/kg [up to 10
mg/day] prednisone equivalents) are permitted in the absence of active
autoimmune disease
- Note: Steroid use for the control of Hodgkin lymphoma symptoms is allowable,
but must be discontinued by cycle 1, day 1
- Patients with peripheral neuropathy > grade 1 at the time of enrollment or patients
with known Charcot-Marie-Tooth syndrome
- Patients with a prior or concurrent malignancy whose natural history or treatment
has the potential to interfere with the safety or efficacy assessment of the
investigational regimen
- Administration of prior chemotherapy, radiation, or antibody-based treatment for cHL
- Prior solid organ transplant
- Prior allogeneic stem cell transplantation
- Live vaccine within 30 days prior to planned day 1 of protocol therapy (e.g.,
measles, mumps, rubella, varicella, yellow fever, rabies, bacillus calmette guerin
[BCG], oral polio vaccine, and oral typhoid). Administration of messenger
ribonucleic acid (mRNA) vaccines are permitted
- Female patients who are pregnant since fetal toxicities and teratogenic effects have
been noted for several of the study drugs. A pregnancy test within 28 days prior to
enrollment is required for female patients of childbearing potential
- Lactating females who plan to breastfeed their infants starting with the first dose
of study therapy and for at least 6 months after the last treatment
- Sexually active patients of reproductive potential who have not agreed to use a
highly effective contraceptive method (failure rate of < 1% per year when used
consistently and correctly) for the duration of their study drug therapy. Following
therapy, patients will be advised to use contraception as per institutional practice
or as listed below for investigational agents, whichever is longer
- Men and women of childbearing potential must continue contraception for a
period of 6 months after last dose of brentuximab vedotin
- Women of child-bearing potential (WOCBP) must continue contraception for a
period of at least 5 months after the last dose of nivolumab
- All patients and/or their parents or legal guardians must sign a written informed
consent
- All institutional, Food and Drug Administration (FDA), and National Cancer Institute
(NCI) requirements for human studies must be met
Gender:
All
Minimum age:
5 Years
Maximum age:
60 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
USA Health Strada Patient Care Center
Address:
City:
Mobile
Zip:
36604
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-388-8721
Investigator:
Last name:
Hamayun Imran
Email:
Principal Investigator
Facility:
Name:
Providence Alaska Medical Center
Address:
City:
Anchorage
Zip:
99508
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
907-212-6871
Email:
AKPAMC.OncologyResearchSupport@providence.org
Investigator:
Last name:
Dan S. Zuckerman
Email:
Principal Investigator
Facility:
Name:
CTCA at Western Regional Medical Center
Address:
City:
Goodyear
Zip:
85338
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
623-207-3000
Investigator:
Last name:
Jeffrey R. Schriber
Email:
Principal Investigator
Facility:
Name:
Arkansas Children's Hospital
Address:
City:
Little Rock
Zip:
72202-3591
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
501-364-7373
Investigator:
Last name:
David L. Becton
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente Downey Medical Center
Address:
City:
Downey
Zip:
90242
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
626-564-3455
Investigator:
Last name:
Robert M. Cooper
Email:
Principal Investigator
Facility:
Name:
City of Hope Comprehensive Cancer Center
Address:
City:
Duarte
Zip:
91010
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-826-4673
Email:
becomingapatient@coh.org
Investigator:
Last name:
Alex F. Herrera
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente Dublin
Address:
City:
Dublin
Zip:
94568
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Investigator:
Last name:
Sachdev P. Thomas
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Fremont
Address:
City:
Fremont
Zip:
94538
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Sachdev P. Thomas
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Fresno
Address:
City:
Fresno
Zip:
93720
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Sachdev P. Thomas
Email:
Principal Investigator
Facility:
Name:
City of Hope Seacliff
Address:
City:
Huntington Beach
Zip:
92648
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
626-256-4673
Investigator:
Last name:
Alex F. Herrera
Email:
Principal Investigator
Facility:
Name:
City of Hope at Irvine Lennar
Address:
City:
Irvine
Zip:
92618
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-467-3411
Investigator:
Last name:
Alex F. Herrera
Email:
Principal Investigator
Facility:
Name:
City of Hope Antelope Valley
Address:
City:
Lancaster
Zip:
93534
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-826-4673
Email:
becomingapatient@coh.org
Investigator:
Last name:
Alex F. Herrera
Email:
Principal Investigator
Facility:
Name:
Loma Linda University Medical Center
Address:
City:
Loma Linda
Zip:
92354
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
909-558-4050
Investigator:
Last name:
Albert Kheradpour
Email:
Principal Investigator
Facility:
Name:
Miller Children's and Women's Hospital Long Beach
Address:
City:
Long Beach
Zip:
90806
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
562-933-5600
Investigator:
Last name:
Jacqueline N. Casillas
Email:
Principal Investigator
Facility:
Name:
City of Hope at Long Beach Elm
Address:
City:
Long Beach
Zip:
90813
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-467-3411
Investigator:
Last name:
Alex F. Herrera
Email:
Principal Investigator
Facility:
Name:
Children's Hospital Los Angeles
Address:
City:
Los Angeles
Zip:
90027
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
323-361-4110
Investigator:
Last name:
Andrew Doan
Email:
Principal Investigator
Facility:
Name:
Cedars Sinai Medical Center
Address:
City:
Los Angeles
Zip:
90048
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
310-423-8965
Investigator:
Last name:
Nicole M. Baca
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Modesto
Address:
City:
Modesto
Zip:
95356
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Sachdev P. Thomas
Email:
Principal Investigator
Facility:
Name:
City of Hope Newport Beach
Address:
City:
Newport Beach
Zip:
92660
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-467-3411
Investigator:
Last name:
Alex F. Herrera
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Oakland
Address:
City:
Oakland
Zip:
94611
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Aarati V. Rao
Email:
Principal Investigator
Facility:
Name:
Children's Hospital of Orange County
Address:
City:
Orange
Zip:
92868
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
714-509-8646
Email:
oncresearch@choc.org
Investigator:
Last name:
Elyssa M. Rubin
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente Downtown Commons
Address:
City:
Sacramento
Zip:
95814
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
kpoct@kp.org
Investigator:
Last name:
Sachdev P. Thomas
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-South Sacramento
Address:
City:
Sacramento
Zip:
95823
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Sachdev P. Thomas
Email:
Principal Investigator
Facility:
Name:
Rady Children's Hospital - San Diego
Address:
City:
San Diego
Zip:
92123
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
858-966-5934
Investigator:
Last name:
William D. Roberts
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-San Francisco
Address:
City:
San Francisco
Zip:
94115
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Sachdev P. Thomas
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Santa Teresa-San Jose
Address:
City:
San Jose
Zip:
95119
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Sachdev P. Thomas
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente San Leandro
Address:
City:
San Leandro
Zip:
94577
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Sachdev P. Thomas
Email:
Principal Investigator
Facility:
Name:
Kaiser San Rafael-Gallinas
Address:
City:
San Rafael
Zip:
94903
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Sachdev P. Thomas
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Santa Rosa
Address:
City:
Santa Rosa
Zip:
95403
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Sachdev P. Thomas
Email:
Principal Investigator
Facility:
Name:
City of Hope South Pasadena
Address:
City:
South Pasadena
Zip:
91030
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-826-4673
Email:
becomingapatient@coh.org
Investigator:
Last name:
Alex F. Herrera
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-South San Francisco
Address:
City:
South San Francisco
Zip:
94080
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Sachdev P. Thomas
Email:
Principal Investigator
Facility:
Name:
City of Hope South Bay
Address:
City:
Torrance
Zip:
90503
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-467-3411
Investigator:
Last name:
Alex F. Herrera
Email:
Principal Investigator
Facility:
Name:
City of Hope Upland
Address:
City:
Upland
Zip:
91786
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-826-4673
Email:
becomingapatient@coh.org
Investigator:
Last name:
Alex F. Herrera
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Vallejo
Address:
City:
Vallejo
Zip:
94589
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Sachdev P. Thomas
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Walnut Creek
Address:
City:
Walnut Creek
Zip:
94596
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Sachdev P. Thomas
Email:
Principal Investigator
Facility:
Name:
Children's Hospital Colorado
Address:
City:
Aurora
Zip:
80045
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
303-764-5056
Email:
josh.b.gordon@nsmtp.kp.org
Investigator:
Last name:
Kelly W. Maloney
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital-Derby Care Center
Address:
City:
Derby
Zip:
06418
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Farzana Pashankar
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital Care Center-Fairfield
Address:
City:
Fairfield
Zip:
06824
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Farzana Pashankar
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital Care Center at Glastonbury
Address:
City:
Glastonbury
Zip:
06033
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Farzana Pashankar
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital Care Center at Greenwich
Address:
City:
Greenwich
Zip:
06830
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Farzana Pashankar
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital Care Center - Guilford
Address:
City:
Guilford
Zip:
06437
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Farzana Pashankar
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital Care Center at Saint Francis
Address:
City:
Hartford
Zip:
06105
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Farzana Pashankar
Email:
Principal Investigator
Facility:
Name:
Connecticut Children's Medical Center
Address:
City:
Hartford
Zip:
06106
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
860-545-9981
Investigator:
Last name:
Michael S. Isakoff
Email:
Principal Investigator
Facility:
Name:
Yale University
Address:
City:
New Haven
Zip:
06520
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Farzana Pashankar
Email:
Principal Investigator
Facility:
Name:
Yale-New Haven Hospital North Haven Medical Center
Address:
City:
North Haven
Zip:
06473
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Farzana Pashankar
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital Care Center at Long Ridge
Address:
City:
Stamford
Zip:
06902
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Farzana Pashankar
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital-Torrington Care Center
Address:
City:
Torrington
Zip:
06790
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Farzana Pashankar
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital Care Center-Trumbull
Address:
City:
Trumbull
Zip:
06611
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Farzana Pashankar
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital-Waterbury Care Center
Address:
City:
Waterbury
Zip:
06708
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Farzana Pashankar
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital Care Center - Waterford
Address:
City:
Waterford
Zip:
06385
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Farzana Pashankar
Email:
Principal Investigator
Facility:
Name:
Alfred I duPont Hospital for Children
Address:
City:
Wilmington
Zip:
19803
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
302-651-5572
Email:
Allison.bruce@nemours.org
Investigator:
Last name:
Vibhuti Agarwal
Email:
Principal Investigator
Facility:
Name:
MedStar Georgetown University Hospital
Address:
City:
Washington
Zip:
20007
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
202-444-2223
Investigator:
Last name:
Caileigh Pudela
Email:
Principal Investigator
Facility:
Name:
Children's National Medical Center
Address:
City:
Washington
Zip:
20010
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
202-476-2800
Email:
OncCRC_OnCall@childrensnational.org
Investigator:
Last name:
Jeffrey S. Dome
Email:
Principal Investigator
Facility:
Name:
Broward Health Medical Center
Address:
City:
Fort Lauderdale
Zip:
33316
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
302-651-5572
Email:
Allison.bruce@nemours.org
Investigator:
Last name:
Hector M. Rodriguez-Cortes
Email:
Principal Investigator
Facility:
Name:
Golisano Children's Hospital of Southwest Florida
Address:
City:
Fort Myers
Zip:
33908
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
239-343-5333
Email:
molly.arnstrom@leehealth.org
Investigator:
Last name:
Emad K. Salman
Email:
Principal Investigator
Facility:
Name:
University of Florida Health Science Center - Gainesville
Address:
City:
Gainesville
Zip:
32610
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
352-273-8010
Email:
cancer-center@ufl.edu
Investigator:
Last name:
Brian Stover
Email:
Principal Investigator
Facility:
Name:
Memorial Regional Hospital/Joe DiMaggio Children's Hospital
Address:
City:
Hollywood
Zip:
33021
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
954-265-1847
Email:
OHR@mhs.net
Investigator:
Last name:
Iftikhar Hanif
Email:
Principal Investigator
Facility:
Name:
Nemours Children's Clinic-Jacksonville
Address:
City:
Jacksonville
Zip:
32207
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
302-651-5572
Email:
Allison.bruce@nemours.org
Investigator:
Last name:
Vibhuti Agarwal
Email:
Principal Investigator
Facility:
Name:
Nicklaus Children's Hospital
Address:
City:
Miami
Zip:
33155
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
888-624-2778
Investigator:
Last name:
Maggie E. Fader
Email:
Principal Investigator
Facility:
Name:
Arnold Palmer Hospital for Children
Address:
City:
Orlando
Zip:
32806
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
321-841-5357
Email:
Jennifer.spinelli@orlandohealth.com
Investigator:
Last name:
Jaime M. Libes-Bander
Email:
Principal Investigator
Facility:
Name:
Nemours Children's Hospital
Address:
City:
Orlando
Zip:
32827
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
302-651-5572
Email:
Allison.bruce@nemours.org
Investigator:
Last name:
Vibhuti Agarwal
Email:
Principal Investigator
Facility:
Name:
Sacred Heart Hospital
Address:
City:
Pensacola
Zip:
32504
Country:
United States
Status:
Suspended
Facility:
Name:
Johns Hopkins All Children's Hospital
Address:
City:
Saint Petersburg
Zip:
33701
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
727-767-4784
Email:
Ashley.Repp@jhmi.edu
Investigator:
Last name:
Jennifer B. Dean
Email:
Principal Investigator
Facility:
Name:
Tampa General Hospital
Address:
City:
Tampa
Zip:
33606
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
813-844-7829
Email:
syapchanyk@tgh.org
Investigator:
Last name:
Andrew J. Galligan
Email:
Principal Investigator
Facility:
Name:
Saint Joseph's Hospital/Children's Hospital-Tampa
Address:
City:
Tampa
Zip:
33607
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
813-357-0849
Email:
jennifer.manns@baycare.org
Investigator:
Last name:
Don E. Eslin
Email:
Principal Investigator
Facility:
Name:
Saint Mary's Hospital
Address:
City:
West Palm Beach
Zip:
33407
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
561-881-2815
Investigator:
Last name:
Matthew D. Ramirez
Email:
Principal Investigator
Facility:
Name:
Grady Health System
Address:
City:
Atlanta
Zip:
30303
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
404-489-9164
Investigator:
Last name:
Pamela B. Allen
Email:
Principal Investigator
Facility:
Name:
Emory Proton Therapy Center
Address:
City:
Atlanta
Zip:
30308
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
404-251-2854
Email:
allyson.anderson@emory.edu
Investigator:
Last name:
Pamela B. Allen
Email:
Principal Investigator
Facility:
Name:
Emory University Hospital Midtown
Address:
City:
Atlanta
Zip:
30308
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
888-946-7447
Investigator:
Last name:
Pamela B. Allen
Email:
Principal Investigator
Facility:
Name:
Emory University Hospital/Winship Cancer Institute
Address:
City:
Atlanta
Zip:
30322
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
404-778-1868
Investigator:
Last name:
Pamela B. Allen
Email:
Principal Investigator
Facility:
Name:
Children's Healthcare of Atlanta - Arthur M Blank Hospital
Address:
City:
Atlanta
Zip:
30329
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
404-785-2025
Email:
Leann.Schilling@choa.org
Investigator:
Last name:
Diana Fridlyand
Email:
Principal Investigator
Facility:
Name:
Emory Saint Joseph's Hospital
Address:
City:
Atlanta
Zip:
30342
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
404-851-7115
Investigator:
Last name:
Pamela B. Allen
Email:
Principal Investigator
Facility:
Name:
Augusta University Medical Center
Address:
City:
Augusta
Zip:
30912
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
706-721-2388
Email:
ga_cares@augusta.edu
Investigator:
Last name:
Colleen H. McDonough
Email:
Principal Investigator
Facility:
Name:
Kapiolani Medical Center for Women and Children
Address:
City:
Honolulu
Zip:
96826
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
808-983-6090
Investigator:
Last name:
Wade T. Kyono
Email:
Principal Investigator
Facility:
Name:
Saint Luke's Cancer Institute - Boise
Address:
City:
Boise
Zip:
83712
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
208-381-2774
Email:
eslinget@slhs.org
Investigator:
Last name:
Dan S. Zuckerman
Email:
Principal Investigator
Facility:
Name:
Saint Luke's Cancer Institute - Fruitland
Address:
City:
Fruitland
Zip:
83619
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
208-381-2774
Email:
eslinget@slhs.org
Investigator:
Last name:
Dan S. Zuckerman
Email:
Principal Investigator
Facility:
Name:
Saint Luke's Cancer Institute - Meridian
Address:
City:
Meridian
Zip:
83642
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
208-381-2774
Email:
eslinget@slhs.org
Investigator:
Last name:
Dan S. Zuckerman
Email:
Principal Investigator
Facility:
Name:
Saint Luke's Cancer Institute - Nampa
Address:
City:
Nampa
Zip:
83687
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
208-381-2774
Email:
eslinget@slhs.org
Investigator:
Last name:
Dan S. Zuckerman
Email:
Principal Investigator
Facility:
Name:
Saint Luke's Cancer Institute - Twin Falls
Address:
City:
Twin Falls
Zip:
83301
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
208-381-2774
Email:
eslinget@slhs.org
Investigator:
Last name:
Dan S. Zuckerman
Email:
Principal Investigator
Facility:
Name:
Rush - Copley Medical Center
Address:
City:
Aurora
Zip:
60504
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
630-978-6212
Email:
Cancer.Research@rushcopley.com
Investigator:
Last name:
Priyank P. Patel
Email:
Principal Investigator
Facility:
Name:
Advocate Good Shepherd Hospital
Address:
City:
Barrington
Zip:
60010
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
847-842-4847
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
Mount Sinai Hospital Medical Center
Address:
City:
Chicago
Zip:
60608
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
773-257-5960
Email:
suhi@sinai.org
Investigator:
Last name:
Pam G. Khosla
Email:
Principal Investigator
Facility:
Name:
Lurie Children's Hospital-Chicago
Address:
City:
Chicago
Zip:
60611
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
773-880-4562
Investigator:
Last name:
Joanna L. Weinstein
Email:
Principal Investigator
Facility:
Name:
Northwestern University
Address:
City:
Chicago
Zip:
60611
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
312-695-1301
Email:
cancer@northwestern.edu
Investigator:
Last name:
Jane N. Winter
Email:
Principal Investigator
Facility:
Name:
University of Illinois
Address:
City:
Chicago
Zip:
60612
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
312-355-3046
Investigator:
Last name:
Dipti S. Dighe
Email:
Principal Investigator
Facility:
Name:
University of Chicago Comprehensive Cancer Center
Address:
City:
Chicago
Zip:
60637
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
773-702-8222
Email:
cancerclinicaltrials@bsd.uchicago.edu
Investigator:
Last name:
Tara O. Henderson
Email:
Principal Investigator
Facility:
Name:
Advocate Illinois Masonic Medical Center
Address:
City:
Chicago
Zip:
60657
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
773-296-5360
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
AMG Crystal Lake - Oncology
Address:
City:
Crystal Lake
Zip:
60014
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
630-929-6129
Email:
advocateresearch@advocate.com
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
Carle at The Riverfront
Address:
City:
Danville
Zip:
61832
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-446-5532
Email:
Research@Carle.com
Investigator:
Last name:
Priyank P. Patel
Email:
Principal Investigator
Facility:
Name:
Decatur Memorial Hospital
Address:
City:
Decatur
Zip:
62526
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
217-876-4762
Email:
morganthaler.jodi@mhsil.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Northwestern Medicine Cancer Center Kishwaukee
Address:
City:
DeKalb
Zip:
60115
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
630-352-5360
Email:
Donald.Smith3@nm.org
Investigator:
Last name:
Jane N. Winter
Email:
Principal Investigator
Facility:
Name:
Advocate Good Samaritan Hospital
Address:
City:
Downers Grove
Zip:
60515
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
630-275-1270
Email:
Barbara.barhamand@advocatehealth.com
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
Carle Physician Group-Effingham
Address:
City:
Effingham
Zip:
62401
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-446-5532
Email:
Research@carle.com
Investigator:
Last name:
Priyank P. Patel
Email:
Principal Investigator
Facility:
Name:
Crossroads Cancer Center
Address:
City:
Effingham
Zip:
62401
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
217-876-4762
Email:
morganthaler.jodi@mhsil.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Advocate Sherman Hospital
Address:
City:
Elgin
Zip:
60123
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
847-429-2907
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
Elmhurst Memorial Hospital
Address:
City:
Elmhurst
Zip:
60126
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
630-758-5460
Email:
Jrohde@emhc.org
Investigator:
Last name:
Joseph Heng
Email:
Principal Investigator
Facility:
Name:
Northwestern Medicine Cancer Center Delnor
Address:
City:
Geneva
Zip:
60134
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
630-352-5360
Email:
Donald.Smith3@nm.org
Investigator:
Last name:
Jane N. Winter
Email:
Principal Investigator
Facility:
Name:
Northwestern Medicine Glenview Outpatient Center
Address:
City:
Glenview
Zip:
60026
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
312-695-1102
Investigator:
Last name:
Jane N. Winter
Email:
Principal Investigator
Facility:
Name:
Northwestern Medicine Grayslake Outpatient Center
Address:
City:
Grayslake
Zip:
60030
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
312-695-1102
Investigator:
Last name:
Jane N. Winter
Email:
Principal Investigator
Facility:
Name:
Advocate South Suburban Hospital
Address:
City:
Hazel Crest
Zip:
60429
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
708-799-9995
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
Northwestern Medicine Lake Forest Hospital
Address:
City:
Lake Forest
Zip:
60045
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
cancertrials@northwestern.edu
Investigator:
Last name:
Jane N. Winter
Email:
Principal Investigator
Facility:
Name:
AMG Libertyville - Oncology
Address:
City:
Libertyville
Zip:
60048
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
630-929-6129
Email:
advocateresearch@advocatehealth.com
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
Condell Memorial Hospital
Address:
City:
Libertyville
Zip:
60048
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
630-929-6129
Email:
advocateresearch@advocatehealth.com
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
Carle Physician Group-Mattoon/Charleston
Address:
City:
Mattoon
Zip:
61938
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-446-5532
Email:
Research@carle.com
Investigator:
Last name:
Priyank P. Patel
Email:
Principal Investigator
Facility:
Name:
Loyola University Medical Center
Address:
City:
Maywood
Zip:
60153
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
708-226-4357
Investigator:
Last name:
Eugene Suh
Email:
Principal Investigator
Facility:
Name:
Edward Hospital/Cancer Center
Address:
City:
Naperville
Zip:
60540
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
630-646-6075
Investigator:
Last name:
Joseph Heng
Email:
Principal Investigator
Facility:
Name:
Advocate Christ Medical Center
Address:
City:
Oak Lawn
Zip:
60453-2699
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-323-8622
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
Advocate Children's Hospital-Oak Lawn
Address:
City:
Oak Lawn
Zip:
60453
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
847-723-7570
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
Northwestern Medicine Orland Park
Address:
City:
Orland Park
Zip:
60462
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
nctnprogram_rhlccc@northwestern.edu
Investigator:
Last name:
Jane N. Winter
Email:
Principal Investigator
Facility:
Name:
Advocate Children's Hospital-Park Ridge
Address:
City:
Park Ridge
Zip:
60068
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
helpdesk@childrensoncologygroup.org
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
Advocate Lutheran General Hospital
Address:
City:
Park Ridge
Zip:
60068
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
847-384-3621
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
Saint Jude Midwest Affiliate
Address:
City:
Peoria
Zip:
61637
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
888-226-4343
Investigator:
Last name:
Prerna Kumar
Email:
Principal Investigator
Facility:
Name:
Edward Hospital/Cancer Center?Plainfield
Address:
City:
Plainfield
Zip:
60585
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
630-646-6075
Email:
Cancerresearch@edward.org
Investigator:
Last name:
Joseph Heng
Email:
Principal Investigator
Facility:
Name:
Memorial Hospital East
Address:
City:
Shiloh
Zip:
62269
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
314-747-9912
Email:
dschwab@wustl.edu
Investigator:
Last name:
Nancy L. Bartlett
Email:
Principal Investigator
Facility:
Name:
Southern Illinois University School of Medicine
Address:
City:
Springfield
Zip:
62702
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
217-545-7929
Investigator:
Last name:
Gregory P. Brandt
Email:
Principal Investigator
Facility:
Name:
Carle Cancer Center
Address:
City:
Urbana
Zip:
61801
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-446-5532
Email:
Research@carle.com
Investigator:
Last name:
Priyank P. Patel
Email:
Principal Investigator
Facility:
Name:
Northwestern Medicine Cancer Center Warrenville
Address:
City:
Warrenville
Zip:
60555
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
630-352-5360
Email:
Donald.Smith3@nm.org
Investigator:
Last name:
Jane N. Winter
Email:
Principal Investigator
Facility:
Name:
Rush-Copley Healthcare Center
Address:
City:
Yorkville
Zip:
60560
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
630-978-6212
Email:
Cancer.Research@rushcopley.com
Investigator:
Last name:
Priyank P. Patel
Email:
Principal Investigator
Facility:
Name:
Riley Hospital for Children
Address:
City:
Indianapolis
Zip:
46202
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-248-1199
Investigator:
Last name:
Jennifer A. Belsky
Email:
Principal Investigator
Facility:
Name:
Ascension Saint Vincent Indianapolis Hospital
Address:
City:
Indianapolis
Zip:
46260
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
317-338-2194
Email:
research@stvincent.org
Investigator:
Last name:
Bassem I. Razzouk
Email:
Principal Investigator
Facility:
Name:
Blank Children's Hospital
Address:
City:
Des Moines
Zip:
50309
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-241-8912
Email:
samantha.mallory@unitypoint.org
Investigator:
Last name:
Samantha L. Mallory
Email:
Principal Investigator
Facility:
Name:
University of Iowa/Holden Comprehensive Cancer Center
Address:
City:
Iowa City
Zip:
52242
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-237-1225
Investigator:
Last name:
David S. Dickens
Email:
Principal Investigator
Facility:
Name:
University of Kentucky/Markey Cancer Center
Address:
City:
Lexington
Zip:
40536
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
859-257-3379
Investigator:
Last name:
James T. Badgett
Email:
Principal Investigator
Facility:
Name:
Norton Children's Hospital
Address:
City:
Louisville
Zip:
40202
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
502-629-5500
Email:
CancerResource@nortonhealthcare.org
Investigator:
Last name:
Michael J. Ferguson
Email:
Principal Investigator
Facility:
Name:
The James Graham Brown Cancer Center at University of Louisville
Address:
City:
Louisville
Zip:
40202
Country:
United States
Status:
Suspended
Facility:
Name:
UofL Health Medical Center Northeast
Address:
City:
Louisville
Zip:
40245
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
502-852-2755
Email:
ctoinfo@louisville.edu
Investigator:
Last name:
Hassaan Yasin
Email:
Principal Investigator
Facility:
Name:
Children's Hospital New Orleans
Address:
City:
New Orleans
Zip:
70118
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
CHResearch@lcmchealth.org
Investigator:
Last name:
Lolie C. Yu
Email:
Principal Investigator
Facility:
Name:
Ochsner Medical Center Jefferson
Address:
City:
New Orleans
Zip:
70121
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
504-842-8084
Email:
Elisemarie.curry@ochsner.org
Investigator:
Last name:
Craig Lotterman
Email:
Principal Investigator
Facility:
Name:
Eastern Maine Medical Center
Address:
City:
Bangor
Zip:
04401
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
207-973-4274
Investigator:
Last name:
Daniel L. Callaway
Email:
Principal Investigator
Facility:
Name:
Sinai Hospital of Baltimore
Address:
City:
Baltimore
Zip:
21215
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
410-601-6120
Email:
pridgely@lifebridgehealth.org
Investigator:
Last name:
Jason M. Fixler
Email:
Principal Investigator
Facility:
Name:
Johns Hopkins University/Sidney Kimmel Cancer Center
Address:
City:
Baltimore
Zip:
21287
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
410-955-8804
Email:
jhcccro@jhmi.edu
Investigator:
Last name:
Stacy L. Cooper
Email:
Principal Investigator
Facility:
Name:
Dana-Farber Cancer Institute
Address:
City:
Boston
Zip:
02215
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-442-3324
Investigator:
Last name:
Ann S. LaCasce
Email:
Principal Investigator
Facility:
Name:
UMass Memorial Medical Center - University Campus
Address:
City:
Worcester
Zip:
01655
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
508-856-3216
Email:
cancer.research@umassmed.edu
Investigator:
Last name:
Stefanie R. Lowas
Email:
Principal Investigator
Facility:
Name:
Trinity Health Saint Joseph Mercy Hospital Ann Arbor
Address:
City:
Ann Arbor
Zip:
48106
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
C S Mott Children's Hospital
Address:
City:
Ann Arbor
Zip:
48109
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-865-1125
Investigator:
Last name:
Emily B. Walling
Email:
Principal Investigator
Facility:
Name:
Bronson Battle Creek
Address:
City:
Battle Creek
Zip:
49017
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
616-391-1230
Email:
crcwm-regulatory@crcwm.org
Investigator:
Last name:
Kathleen J. Yost
Email:
Principal Investigator
Facility:
Name:
Trinity Health IHA Medical Group Hematology Oncology - Brighton
Address:
City:
Brighton
Zip:
48114
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Trinity Health IHA Medical Group Hematology Oncology - Canton
Address:
City:
Canton
Zip:
48188
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
Address:
City:
Chelsea
Zip:
48118
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Corewell Health Dearborn Hospital
Address:
City:
Dearborn
Zip:
48124
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
248-551-7695
Investigator:
Last name:
Laura K. Gowans
Email:
Principal Investigator
Facility:
Name:
Children's Hospital of Michigan
Address:
City:
Detroit
Zip:
48201
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
helpdesk@childrensoncologygroup.org
Investigator:
Last name:
Meret Henry
Email:
Principal Investigator
Facility:
Name:
Michigan State University Clinical Center
Address:
City:
East Lansing
Zip:
48824
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
517-975-9547
Investigator:
Last name:
Laura E. Agresta
Email:
Principal Investigator
Facility:
Name:
Corewell Health Farmington Hills Hospital
Address:
City:
Farmington Hills
Zip:
48336
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
248-551-7695
Investigator:
Last name:
Laura K. Gowans
Email:
Principal Investigator
Facility:
Name:
Corewell Health Grand Rapids Hospitals - Butterworth Hospital
Address:
City:
Grand Rapids
Zip:
49503
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
616-391-1230
Email:
crcwm-regulatory@crcwm.org
Investigator:
Last name:
Kathleen J. Yost
Email:
Principal Investigator
Facility:
Name:
Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital
Address:
City:
Grand Rapids
Zip:
49503
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
616-267-1925
Email:
crcwm-regulatory@crcwm.org
Investigator:
Last name:
Kathleen J. Yost
Email:
Principal Investigator
Facility:
Name:
Trinity Health Grand Rapids Hospital
Address:
City:
Grand Rapids
Zip:
49503
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
616-391-1230
Email:
crcwm-regulatory@crcwm.org
Investigator:
Last name:
Kathleen J. Yost
Email:
Principal Investigator
Facility:
Name:
Bronson Methodist Hospital
Address:
City:
Kalamazoo
Zip:
49007
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
616-391-1230
Email:
crcwm-regulatory@crcwm.org
Investigator:
Last name:
Kathleen J. Yost
Email:
Principal Investigator
Facility:
Name:
West Michigan Cancer Center
Address:
City:
Kalamazoo
Zip:
49007
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
616-391-1230
Email:
crcwm-regulatory@crcwm.org
Investigator:
Last name:
Kathleen J. Yost
Email:
Principal Investigator
Facility:
Name:
Ascension Borgess Cancer Center
Address:
City:
Kalamazoo
Zip:
49009
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
616-391-1230
Email:
crcwm-regulatory@crcwm.org
Investigator:
Last name:
Kathleen J. Yost
Email:
Principal Investigator
Facility:
Name:
Trinity Health Saint Mary Mercy Livonia Hospital
Address:
City:
Livonia
Zip:
48154
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Trinity Health Muskegon Hospital
Address:
City:
Muskegon
Zip:
49444
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
616-391-1230
Email:
crcwm-regulatory@crcwm.org
Investigator:
Last name:
Kathleen J. Yost
Email:
Principal Investigator
Facility:
Name:
Cancer and Hematology Centers of Western Michigan - Norton Shores
Address:
City:
Norton Shores
Zip:
49444
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
616-391-1230
Email:
connie.szczepanek@crcwm.org
Investigator:
Last name:
Kathleen J. Yost
Email:
Principal Investigator
Facility:
Name:
Corewell Health Reed City Hospital
Address:
City:
Reed City
Zip:
49677
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
616-391-1230
Email:
crcwm-regulatory@crcwm.org
Investigator:
Last name:
Kathleen J. Yost
Email:
Principal Investigator
Facility:
Name:
Corewell Health Children's
Address:
City:
Royal Oak
Zip:
48073
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
248-551-7695
Investigator:
Last name:
Laura K. Gowans
Email:
Principal Investigator
Facility:
Name:
Corewell Health William Beaumont University Hospital
Address:
City:
Royal Oak
Zip:
48073
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
248-551-7695
Investigator:
Last name:
Laura K. Gowans
Email:
Principal Investigator
Facility:
Name:
Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center
Address:
City:
Saint Joseph
Zip:
49085
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
616-391-1230
Email:
crcwm-regulatory@crcwm.org
Investigator:
Last name:
Kathleen J. Yost
Email:
Principal Investigator
Facility:
Name:
Munson Medical Center
Address:
City:
Traverse City
Zip:
49684
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
616-391-1230
Email:
crcwm-regulatory@crcwm.org
Investigator:
Last name:
Kathleen J. Yost
Email:
Principal Investigator
Facility:
Name:
Corewell Health Beaumont Troy Hospital
Address:
City:
Troy
Zip:
48085
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
248-551-7695
Investigator:
Last name:
Laura K. Gowans
Email:
Principal Investigator
Facility:
Name:
University of Michigan Health - West
Address:
City:
Wyoming
Zip:
49519
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
616-391-1230
Email:
crcwm-regulatory@crcwm.org
Investigator:
Last name:
Kathleen J. Yost
Email:
Principal Investigator
Facility:
Name:
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
Address:
City:
Ypsilanti
Zip:
48197
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Children's Hospitals and Clinics of Minnesota - Minneapolis
Address:
City:
Minneapolis
Zip:
55404
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
612-813-5913
Email:
pauline.mitby@childrensmn.org
Investigator:
Last name:
Michael K. Richards
Email:
Principal Investigator
Facility:
Name:
University of Minnesota/Masonic Cancer Center
Address:
City:
Minneapolis
Zip:
55455
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
612-624-2620
Investigator:
Last name:
Peter M. Gordon
Email:
Principal Investigator
Facility:
Name:
Mayo Clinic in Rochester
Address:
City:
Rochester
Zip:
55905
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
855-776-0015
Investigator:
Last name:
Mira Kohorst
Email:
Principal Investigator
Facility:
Name:
University of Mississippi Medical Center
Address:
City:
Jackson
Zip:
39216
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
601-815-6700
Investigator:
Last name:
Betty L. Herrington
Email:
Principal Investigator
Facility:
Name:
Saint Luke's Hospital
Address:
City:
Chesterfield
Zip:
63017
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
314-205-6936
Investigator:
Last name:
Mark J. Fesler
Email:
Principal Investigator
Facility:
Name:
Siteman Cancer Center at West County Hospital
Address:
City:
Creve Coeur
Zip:
63141
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-600-3606
Email:
info@siteman.wustl.edu
Investigator:
Last name:
Nancy L. Bartlett
Email:
Principal Investigator
Facility:
Name:
Children's Mercy Hospitals and Clinics
Address:
City:
Kansas City
Zip:
64108
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
816-302-6808
Email:
rryan@cmh.edu
Investigator:
Last name:
Keith J. August
Email:
Principal Investigator
Facility:
Name:
Cardinal Glennon Children's Medical Center
Address:
City:
Saint Louis
Zip:
63104
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
314-268-4000
Investigator:
Last name:
William S. Ferguson
Email:
Principal Investigator
Facility:
Name:
Washington University School of Medicine
Address:
City:
Saint Louis
Zip:
63110
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-600-3606
Email:
info@siteman.wustl.edu
Investigator:
Last name:
Nancy L. Bartlett
Email:
Principal Investigator
Facility:
Name:
Siteman Cancer Center-South County
Address:
City:
Saint Louis
Zip:
63129
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-600-3606
Email:
info@siteman.wustl.edu
Investigator:
Last name:
Nancy L. Bartlett
Email:
Principal Investigator
Facility:
Name:
Siteman Cancer Center at Christian Hospital
Address:
City:
Saint Louis
Zip:
63136
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-600-3606
Email:
info@siteman.wustl.edu
Investigator:
Last name:
Nancy L. Bartlett
Email:
Principal Investigator
Facility:
Name:
Mercy Hospital Saint Louis
Address:
City:
Saint Louis
Zip:
63141
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
314-251-7066
Investigator:
Last name:
Robin D. Hanson
Email:
Principal Investigator
Facility:
Name:
Siteman Cancer Center at Saint Peters Hospital
Address:
City:
Saint Peters
Zip:
63376
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-600-3606
Email:
info@siteman.wustl.edu
Investigator:
Last name:
Nancy L. Bartlett
Email:
Principal Investigator
Facility:
Name:
Children's Hospital and Medical Center of Omaha
Address:
City:
Omaha
Zip:
68114
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
402-955-3949
Investigator:
Last name:
Jill C. Beck
Email:
Principal Investigator
Facility:
Name:
University of Nebraska Medical Center
Address:
City:
Omaha
Zip:
68198
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
402-559-6941
Email:
unmcrsa@unmc.edu
Investigator:
Last name:
Jill C. Beck
Email:
Principal Investigator
Facility:
Name:
Alliance for Childhood Diseases/Cure 4 the Kids Foundation
Address:
City:
Las Vegas
Zip:
89135
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
702-384-0013
Email:
research@sncrf.org
Investigator:
Last name:
Alan K. Ikeda
Email:
Principal Investigator
Facility:
Name:
Renown Regional Medical Center
Address:
City:
Reno
Zip:
89502
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
702-384-0013
Email:
research@sncrf.org
Investigator:
Last name:
Alan K. Ikeda
Email:
Principal Investigator
Facility:
Name:
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
Address:
City:
Lebanon
Zip:
03756
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-639-6918
Email:
cancer.research.nurse@dartmouth.edu
Investigator:
Last name:
Angela Ricci
Email:
Principal Investigator
Facility:
Name:
Cooper Hospital University Medical Center
Address:
City:
Camden
Zip:
08103
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
856-325-6757
Investigator:
Last name:
Sushil Ghimire
Email:
Principal Investigator
Facility:
Name:
Trinitas Hospital and Comprehensive Cancer Center - Williamson Street Campus
Address:
City:
Elizabeth
Zip:
07207
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
908-994-8000
Investigator:
Last name:
Richard A. Drachtman
Email:
Principal Investigator
Facility:
Name:
Hackensack University Medical Center
Address:
City:
Hackensack
Zip:
07601
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
551-996-2897
Investigator:
Last name:
Burton E. Appel
Email:
Principal Investigator
Facility:
Name:
Jersey City Medical Center
Address:
City:
Jersey City
Zip:
07302
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
888-823-5923
Email:
ctsucontact@westat.com
Investigator:
Last name:
Richard A. Drachtman
Email:
Principal Investigator
Facility:
Name:
Saint Barnabas Medical Center
Address:
City:
Livingston
Zip:
07039
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
973-322-2934
Email:
joanne.loeb@rwjbh.org
Investigator:
Last name:
Richard A. Drachtman
Email:
Principal Investigator
Facility:
Name:
Monmouth Medical Center
Address:
City:
Long Branch
Zip:
07740
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
732-923-6564
Email:
mary.danish@rwjbh.org
Investigator:
Last name:
Richard A. Drachtman
Email:
Principal Investigator
Facility:
Name:
Morristown Medical Center
Address:
City:
Morristown
Zip:
07960
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
973-971-5900
Investigator:
Last name:
Kathryn L. Laurie
Email:
Principal Investigator
Facility:
Name:
Jersey Shore Medical Center
Address:
City:
Neptune
Zip:
07753
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
732-776-4240
Investigator:
Last name:
Burton E. Appel
Email:
Principal Investigator
Facility:
Name:
Saint Peter's University Hospital
Address:
City:
New Brunswick
Zip:
08901
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
732-745-8600
Phone ext:
6163
Email:
kcovert@saintpetersuh.com
Investigator:
Last name:
Nibal A. Zaghloul
Email:
Principal Investigator
Facility:
Name:
Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital
Address:
City:
New Brunswick
Zip:
08903
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
732-235-8675
Investigator:
Last name:
Richard A. Drachtman
Email:
Principal Investigator
Facility:
Name:
Rutgers Cancer Institute of New Jersey
Address:
City:
New Brunswick
Zip:
08903
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
732-235-7356
Investigator:
Last name:
Richard A. Drachtman
Email:
Principal Investigator
Facility:
Name:
Newark Beth Israel Medical Center
Address:
City:
Newark
Zip:
07112
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
973-926-7230
Email:
Christine.Kosmides@rwjbh.org
Investigator:
Last name:
Richard A. Drachtman
Email:
Principal Investigator
Facility:
Name:
Saint Joseph's Regional Medical Center
Address:
City:
Paterson
Zip:
07503
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
973-754-2207
Email:
HallL@sjhmc.org
Investigator:
Last name:
Alissa Kahn
Email:
Principal Investigator
Facility:
Name:
Community Medical Center
Address:
City:
Toms River
Zip:
08755
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
732-557-8294
Email:
Lennette.Gonzales@rwjbh.org
Investigator:
Last name:
Richard A. Drachtman
Email:
Principal Investigator
Facility:
Name:
Presbyterian Hospital
Address:
City:
Albuquerque
Zip:
87106
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
505-559-6113
Email:
wburman@phs.org
Investigator:
Last name:
Xiaxin Li
Email:
Principal Investigator
Facility:
Name:
University of New Mexico Cancer Center
Address:
City:
Albuquerque
Zip:
87106
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
505-925-0348
Email:
HSC-ClinicalTrialInfo@salud.unm.edu
Investigator:
Last name:
Jessica M. Valdez
Email:
Principal Investigator
Facility:
Name:
Albany Medical Center
Address:
City:
Albany
Zip:
12208
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
518-262-5513
Investigator:
Last name:
Lauren R. Weintraub
Email:
Principal Investigator
Facility:
Name:
Montefiore Medical Center - Moses Campus
Address:
City:
Bronx
Zip:
10467
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
718-379-6866
Email:
eskwak@montefiore.org
Investigator:
Last name:
Alice Lee
Email:
Principal Investigator
Facility:
Name:
Roswell Park Cancer Institute
Address:
City:
Buffalo
Zip:
14263
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-767-9355
Email:
askroswell@roswellpark.org
Investigator:
Last name:
Kara M. Kelly
Email:
Principal Investigator
Facility:
Name:
Glens Falls Hospital
Address:
City:
Glens Falls
Zip:
12801
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
518-926-6700
Investigator:
Last name:
Christopher R. Mason
Email:
Principal Investigator
Facility:
Name:
NYU Langone Hospital - Long Island
Address:
City:
Mineola
Zip:
11501
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
212-263-4432
Email:
cancertrials@nyulangone.org
Investigator:
Last name:
Chana L. Glasser
Email:
Principal Investigator
Facility:
Name:
The Steven and Alexandra Cohen Children's Medical Center of New York
Address:
City:
New Hyde Park
Zip:
11040
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
718-470-3460
Investigator:
Last name:
Arlene S. Redner
Email:
Principal Investigator
Facility:
Name:
Laura and Isaac Perlmutter Cancer Center at NYU Langone
Address:
City:
New York
Zip:
10016
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
CancerTrials@nyulangone.org
Investigator:
Last name:
Elizabeth A. Raetz
Email:
Principal Investigator
Facility:
Name:
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
Address:
City:
New York
Zip:
10032
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
212-342-5162
Email:
cancerclinicaltrials@cumc.columbia.edu
Investigator:
Last name:
Nobuko Hijiya
Email:
Principal Investigator
Facility:
Name:
Memorial Sloan Kettering Cancer Center
Address:
City:
New York
Zip:
10065
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
212-639-7592
Investigator:
Last name:
Christopher J. Forlenza
Email:
Principal Investigator
Facility:
Name:
NYP/Weill Cornell Medical Center
Address:
City:
New York
Zip:
10065
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
212-746-1848
Investigator:
Last name:
Lisa G. Roth
Email:
Principal Investigator
Facility:
Name:
University of Rochester
Address:
City:
Rochester
Zip:
14642
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
585-275-5830
Investigator:
Last name:
Paul M. Barr
Email:
Principal Investigator
Facility:
Name:
Stony Brook University Medical Center
Address:
City:
Stony Brook
Zip:
11794
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-862-2215
Investigator:
Last name:
Laura E. Hogan
Email:
Principal Investigator
Facility:
Name:
State University of New York Upstate Medical University
Address:
City:
Syracuse
Zip:
13210
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
315-464-5476
Investigator:
Last name:
Melanie A. Comito
Email:
Principal Investigator
Facility:
Name:
Wilmot Cancer Institute at Webster
Address:
City:
Webster
Zip:
14580
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
WCICTOresearch@urmc.rochester.edu
Investigator:
Last name:
Paul M. Barr
Email:
Principal Investigator
Facility:
Name:
Mission Hospital
Address:
City:
Asheville
Zip:
28801
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
828-213-7055
Email:
NCDV.ResearchRegulatory@HCAHealthcare.com
Investigator:
Last name:
Douglas J. Scothorn
Email:
Principal Investigator
Facility:
Name:
UNC Lineberger Comprehensive Cancer Center
Address:
City:
Chapel Hill
Zip:
27599
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-668-0683
Email:
cancerclinicaltrials@med.unc.edu
Investigator:
Last name:
Natalie S. Grover
Email:
Principal Investigator
Facility:
Name:
Carolinas Medical Center/Levine Cancer Institute
Address:
City:
Charlotte
Zip:
28203
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-804-9376
Investigator:
Last name:
Joel A. Kaplan
Email:
Principal Investigator
Facility:
Name:
Duke University Medical Center
Address:
City:
Durham
Zip:
27710
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
888-275-3853
Investigator:
Last name:
Jessica M. Sun
Email:
Principal Investigator
Facility:
Name:
East Carolina University
Address:
City:
Greenville
Zip:
27834
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
252-744-1015
Email:
eubankss@ecu.edu
Investigator:
Last name:
Andrea R. Whitfield
Email:
Principal Investigator
Facility:
Name:
Wake Forest University Health Sciences
Address:
City:
Winston-Salem
Zip:
27157
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
336-713-6771
Investigator:
Last name:
Thomas W. McLean
Email:
Principal Investigator
Facility:
Name:
Sanford Broadway Medical Center
Address:
City:
Fargo
Zip:
58122
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
701-323-5760
Email:
OncologyClinicalTrialsFargo@sanfordhealth.org
Investigator:
Last name:
Samuel J. Milanovich
Email:
Principal Investigator
Facility:
Name:
Children's Hospital Medical Center of Akron
Address:
City:
Akron
Zip:
44308
Country:
United States
Status:
Suspended
Facility:
Name:
Cincinnati Children's Hospital Medical Center
Address:
City:
Cincinnati
Zip:
45229
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
513-636-2799
Email:
cancer@cchmc.org
Investigator:
Last name:
Robin E. Norris
Email:
Principal Investigator
Facility:
Name:
Rainbow Babies and Childrens Hospital
Address:
City:
Cleveland
Zip:
44106
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
216-844-5437
Investigator:
Last name:
Duncan S. Stearns
Email:
Principal Investigator
Facility:
Name:
Nationwide Children's Hospital
Address:
City:
Columbus
Zip:
43205
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
614-722-6039
Email:
Melinda.Triplet@nationwidechildrens.org
Investigator:
Last name:
Mark A. Ranalli
Email:
Principal Investigator
Facility:
Name:
Dayton Children's Hospital
Address:
City:
Dayton
Zip:
45404
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-228-4055
Investigator:
Last name:
Jordan M. Wright
Email:
Principal Investigator
Facility:
Name:
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital
Address:
City:
Toledo
Zip:
43606
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
419-824-1842
Email:
PCIOncResearch@promedica.org
Investigator:
Last name:
Jamie L. Dargart
Email:
Principal Investigator
Facility:
Name:
University of Oklahoma Health Sciences Center
Address:
City:
Oklahoma City
Zip:
73104
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
405-271-8777
Email:
ou-clinical-trials@ouhsc.edu
Investigator:
Last name:
Rene Y. McNall-Knapp
Email:
Principal Investigator
Facility:
Name:
Providence Willamette Falls Medical Center
Address:
City:
Oregon City
Zip:
97045
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
503-215-2614
Email:
CanRsrchStudies@providence.org
Investigator:
Last name:
Dan S. Zuckerman
Email:
Principal Investigator
Facility:
Name:
Providence Portland Medical Center
Address:
City:
Portland
Zip:
97213
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
503-215-2614
Email:
CanRsrchStudies@providence.org
Investigator:
Last name:
Dan S. Zuckerman
Email:
Principal Investigator
Facility:
Name:
Providence Saint Vincent Medical Center
Address:
City:
Portland
Zip:
97225
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
503-215-2614
Email:
CanRsrchStudies@providence.org
Investigator:
Last name:
Dan S. Zuckerman
Email:
Principal Investigator
Facility:
Name:
Legacy Emanuel Children's Hospital
Address:
City:
Portland
Zip:
97227
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
503-413-2560
Investigator:
Last name:
Jason M. Glover
Email:
Principal Investigator
Facility:
Name:
Oregon Health and Science University
Address:
City:
Portland
Zip:
97239
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
503-494-1080
Email:
trials@ohsu.edu
Investigator:
Last name:
Bill H. Chang
Email:
Principal Investigator
Facility:
Name:
Geisinger Medical Center
Address:
City:
Danville
Zip:
17822
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
570-271-5251
Email:
HemonCCTrials@geisinger.edu
Investigator:
Last name:
Jagadeesh Ramdas
Email:
Principal Investigator
Facility:
Name:
Penn State Children's Hospital
Address:
City:
Hershey
Zip:
17033
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
717-531-6012
Investigator:
Last name:
Lisa M. McGregor
Email:
Principal Investigator
Facility:
Name:
Children's Hospital of Philadelphia
Address:
City:
Philadelphia
Zip:
19104
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
267-425-5544
Email:
CancerTrials@email.chop.edu
Investigator:
Last name:
Leslie S. Kersun
Email:
Principal Investigator
Facility:
Name:
Saint Christopher's Hospital for Children
Address:
City:
Philadelphia
Zip:
19134
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
215-427-8991
Investigator:
Last name:
Gregory E. Halligan
Email:
Principal Investigator
Facility:
Name:
Children's Hospital of Pittsburgh of UPMC
Address:
City:
Pittsburgh
Zip:
15224
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
412-692-8570
Email:
jean.tersak@chp.edu
Investigator:
Last name:
Jean M. Tersak
Email:
Principal Investigator
Facility:
Name:
Rhode Island Hospital
Address:
City:
Providence
Zip:
02903
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
401-444-1488
Investigator:
Last name:
Bradley DeNardo
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital Care Center - Westerly
Address:
City:
Westerly
Zip:
02891
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Farzana Pashankar
Email:
Principal Investigator
Facility:
Name:
Prisma Health Cancer Institute - Spartanburg
Address:
City:
Boiling Springs
Zip:
29316
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
864-241-6251
Investigator:
Last name:
Aniket Saha
Email:
Principal Investigator
Facility:
Name:
Medical University of South Carolina
Address:
City:
Charleston
Zip:
29425
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
843-792-9321
Email:
hcc-clinical-trials@musc.edu
Investigator:
Last name:
Jacqueline M. Kraveka
Email:
Principal Investigator
Facility:
Name:
Prisma Health Richland Hospital
Address:
City:
Columbia
Zip:
29203
Country:
United States
Status:
Suspended
Facility:
Name:
Saint Francis Hospital
Address:
City:
Greenville
Zip:
29601
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
864-603-6213
Email:
melissa_beckman@bshsi.org
Investigator:
Last name:
Howland E. Crosswell
Email:
Principal Investigator
Facility:
Name:
BI-LO Charities Children's Cancer Center
Address:
City:
Greenville
Zip:
29605
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
864-241-6251
Investigator:
Last name:
Aniket Saha
Email:
Principal Investigator
Facility:
Name:
Saint Francis Cancer Center
Address:
City:
Greenville
Zip:
29607
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
864-603-6213
Email:
melissa_beckman@bshsi.org
Investigator:
Last name:
Howland E. Crosswell
Email:
Principal Investigator
Facility:
Name:
Prisma Health Cancer Institute - Eastside
Address:
City:
Greenville
Zip:
29615
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
864-241-6251
Investigator:
Last name:
Aniket Saha
Email:
Principal Investigator
Facility:
Name:
Sanford USD Medical Center - Sioux Falls
Address:
City:
Sioux Falls
Zip:
57117-5134
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
605-312-3320
Email:
OncologyClinicalTrialsSF@SanfordHealth.org
Investigator:
Last name:
Kayelyn J. Wagner
Email:
Principal Investigator
Facility:
Name:
T C Thompson Children's Hospital
Address:
City:
Chattanooga
Zip:
37403
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
423-778-7289
Investigator:
Last name:
Benjamin A. Mixon
Email:
Principal Investigator
Facility:
Name:
East Tennessee Childrens Hospital
Address:
City:
Knoxville
Zip:
37916
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
865-541-8266
Investigator:
Last name:
Susan E. Spiller
Email:
Principal Investigator
Facility:
Name:
The Children's Hospital at TriStar Centennial
Address:
City:
Nashville
Zip:
37203
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
615-342-1919
Investigator:
Last name:
Jennifer A. Domm
Email:
Principal Investigator
Facility:
Name:
Vanderbilt University/Ingram Cancer Center
Address:
City:
Nashville
Zip:
37232
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-811-8480
Investigator:
Last name:
Christine M. Smith
Email:
Principal Investigator
Facility:
Name:
Dell Children's Medical Center of Central Texas
Address:
City:
Austin
Zip:
78723
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
512-628-1902
Email:
TXAUS-DL-SFCHemonc.research@ascension.org
Investigator:
Last name:
Shannon M. Cohn
Email:
Principal Investigator
Facility:
Name:
Driscoll Children's Hospital
Address:
City:
Corpus Christi
Zip:
78411
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
361-694-5311
Email:
Crystal.DeLosSantos@dchstx.org
Investigator:
Last name:
Nkechi I. Mba
Email:
Principal Investigator
Facility:
Name:
Medical City Dallas Hospital
Address:
City:
Dallas
Zip:
75230
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
972-566-5588
Investigator:
Last name:
Stanton C. Goldman
Email:
Principal Investigator
Facility:
Name:
UT Southwestern/Simmons Cancer Center-Dallas
Address:
City:
Dallas
Zip:
75390
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
214-648-7097
Email:
canceranswerline@UTSouthwestern.edu
Investigator:
Last name:
Ksenya Shliakhtsitsava
Email:
Principal Investigator
Facility:
Name:
El Paso Children's Hospital
Address:
City:
El Paso
Zip:
79905
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
915-298-5444
Email:
ranjan.bista@ttuhsc.edu
Investigator:
Last name:
Benjamin Carcamo
Email:
Principal Investigator
Facility:
Name:
Cook Children's Medical Center
Address:
City:
Fort Worth
Zip:
76104
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
682-885-2103
Email:
CookChildrensResearch@cookchildrens.org
Investigator:
Last name:
Karen H. Albritton
Email:
Principal Investigator
Facility:
Name:
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
Address:
City:
Houston
Zip:
77030
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
713-798-1354
Email:
burton@bcm.edu
Investigator:
Last name:
Kala Y. Kamdar
Email:
Principal Investigator
Facility:
Name:
M D Anderson Cancer Center
Address:
City:
Houston
Zip:
77030
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-632-6789
Email:
askmdanderson@mdanderson.org
Investigator:
Last name:
Najat C. Daw
Email:
Principal Investigator
Facility:
Name:
Covenant Children's Hospital
Address:
City:
Lubbock
Zip:
79410
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
806-725-8657
Email:
mbisbee@providence.org
Investigator:
Last name:
Kishor M. Bhende
Email:
Principal Investigator
Facility:
Name:
UMC Cancer Center / UMC Health System
Address:
City:
Lubbock
Zip:
79415
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
806-775-8590
Investigator:
Last name:
Erin K. Barr
Email:
Principal Investigator
Facility:
Name:
Children's Hospital of San Antonio
Address:
City:
San Antonio
Zip:
78207
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
210-704-2894
Email:
bridget.medina@christushealth.org
Investigator:
Last name:
Julie Voeller
Email:
Principal Investigator
Facility:
Name:
Methodist Children's Hospital of South Texas
Address:
City:
San Antonio
Zip:
78229
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
210-575-6240
Email:
Vinod.GidvaniDiaz@hcahealthcare.com
Investigator:
Last name:
Jose M. Esquilin
Email:
Principal Investigator
Facility:
Name:
University of Texas Health Science Center at San Antonio
Address:
City:
San Antonio
Zip:
78229
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
210-450-3800
Email:
phoresearchoffice@uthscsa.edu
Investigator:
Last name:
Allison C. Grimes
Email:
Principal Investigator
Facility:
Name:
Huntsman Cancer Institute/University of Utah
Address:
City:
Salt Lake City
Zip:
84112
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
888-424-2100
Email:
cancerinfo@hci.utah.edu
Investigator:
Last name:
Boyu Hu
Email:
Principal Investigator
Facility:
Name:
Primary Children's Hospital
Address:
City:
Salt Lake City
Zip:
84113
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
801-585-5270
Investigator:
Last name:
Mallorie B. Heneghan
Email:
Principal Investigator
Facility:
Name:
University of Vermont and State Agricultural College
Address:
City:
Burlington
Zip:
05405
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
802-656-8990
Email:
rpo@uvm.edu
Investigator:
Last name:
Jessica L. Heath
Email:
Principal Investigator
Facility:
Name:
University of Virginia Cancer Center
Address:
City:
Charlottesville
Zip:
22908
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
434-243-6303
Email:
uvacancertrials@hscmail.mcc.virginia.edu
Investigator:
Last name:
Brian C. Belyea
Email:
Principal Investigator
Facility:
Name:
Inova Fairfax Hospital
Address:
City:
Falls Church
Zip:
22042
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
703-208-6650
Email:
Stephanie.VanBebber@inova.org
Investigator:
Last name:
Robin Y. Dulman
Email:
Principal Investigator
Facility:
Name:
Children's Hospital of The King's Daughters
Address:
City:
Norfolk
Zip:
23507
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
757-668-7243
Email:
CCBDCresearch@chkd.org
Investigator:
Last name:
Eric J. Lowe
Email:
Principal Investigator
Facility:
Name:
Virginia Commonwealth University/Massey Cancer Center
Address:
City:
Richmond
Zip:
23298
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
CTOclinops@vcu.edu
Investigator:
Last name:
Jordyn R. Griffin
Email:
Principal Investigator
Facility:
Name:
Carilion Children's
Address:
City:
Roanoke
Zip:
24014
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
540-266-6238
Email:
wpmccarty@carilionclinic.org
Investigator:
Last name:
Erwood G. Edwards
Email:
Principal Investigator
Facility:
Name:
Seattle Children's Hospital
Address:
City:
Seattle
Zip:
98105
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
866-987-2000
Investigator:
Last name:
Sarah E. Leary
Email:
Principal Investigator
Facility:
Name:
Providence Sacred Heart Medical Center and Children's Hospital
Address:
City:
Spokane
Zip:
99204
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-228-6618
Email:
HopeBeginsHere@providence.org
Investigator:
Last name:
Judy L. Felgenhauer
Email:
Principal Investigator
Facility:
Name:
Mary Bridge Children's Hospital and Health Center
Address:
City:
Tacoma
Zip:
98405
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
253-403-1461
Email:
research@multicare.org
Investigator:
Last name:
Robert G. Irwin
Email:
Principal Investigator
Facility:
Name:
Edwards Comprehensive Cancer Center
Address:
City:
Huntington
Zip:
25701
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
304-399-6566
Email:
Christina.Cole@chhi.org
Investigator:
Last name:
Mark A. Ranalli
Email:
Principal Investigator
Facility:
Name:
Aurora Cancer Care-Southern Lakes VLCC
Address:
City:
Burlington
Zip:
53105
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
Aurora Saint Luke's South Shore
Address:
City:
Cudahy
Zip:
53110
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
Aurora Health Care Germantown Health Center
Address:
City:
Germantown
Zip:
53022
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
Aurora Cancer Care-Grafton
Address:
City:
Grafton
Zip:
53024
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
Saint Vincent Hospital Cancer Center Green Bay
Address:
City:
Green Bay
Zip:
54301
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
920-433-8889
Email:
ewd_research_admin@hshs.org
Investigator:
Last name:
Catherine A. Long
Email:
Principal Investigator
Facility:
Name:
Aurora BayCare Medical Center
Address:
City:
Green Bay
Zip:
54311
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
Aurora Cancer Care-Kenosha South
Address:
City:
Kenosha
Zip:
53142
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
Gundersen Lutheran Medical Center
Address:
City:
La Crosse
Zip:
54601
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
608-775-2385
Email:
cancerctr@gundersenhealth.org
Investigator:
Last name:
Kurt Oettel
Email:
Principal Investigator
Facility:
Name:
University of Wisconsin Carbone Cancer Center - University Hospital
Address:
City:
Madison
Zip:
53792
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-622-8922
Email:
clinicaltrials@cancer.wisc.edu
Investigator:
Last name:
Priyanka Pophali
Email:
Principal Investigator
Facility:
Name:
Aurora Bay Area Medical Group-Marinette
Address:
City:
Marinette
Zip:
54143
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
Marshfield Medical Center-Marshfield
Address:
City:
Marshfield
Zip:
54449
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-782-8581
Email:
oncology.clinical.trials@marshfieldresearch.org
Investigator:
Last name:
Jon M. Brandt
Email:
Principal Investigator
Facility:
Name:
Aurora Cancer Care-Milwaukee
Address:
City:
Milwaukee
Zip:
53209
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
Aurora Saint Luke's Medical Center
Address:
City:
Milwaukee
Zip:
53215
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
Aurora Sinai Medical Center
Address:
City:
Milwaukee
Zip:
53233
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
ProHealth D N Greenwald Center
Address:
City:
Mukwonago
Zip:
53149
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
research.institute@phci.org
Investigator:
Last name:
Timothy R. Wassenaar
Email:
Principal Investigator
Facility:
Name:
ProHealth Oconomowoc Memorial Hospital
Address:
City:
Oconomowoc
Zip:
53066
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
262-928-7878
Investigator:
Last name:
Timothy R. Wassenaar
Email:
Principal Investigator
Facility:
Name:
Vince Lombardi Cancer Clinic - Oshkosh
Address:
City:
Oshkosh
Zip:
54904
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
Aurora Cancer Care-Racine
Address:
City:
Racine
Zip:
53406
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
Vince Lombardi Cancer Clinic-Sheboygan
Address:
City:
Sheboygan
Zip:
53081
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
Saint Vincent Hospital Cancer Center at Sturgeon Bay
Address:
City:
Sturgeon Bay
Zip:
54235-1495
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
920-433-8889
Email:
ewd_research_admin@hshs.org
Investigator:
Last name:
Catherine A. Long
Email:
Principal Investigator
Facility:
Name:
Aurora Medical Center in Summit
Address:
City:
Summit
Zip:
53066
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
Vince Lombardi Cancer Clinic-Two Rivers
Address:
City:
Two Rivers
Zip:
54241
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
UW Cancer Center at ProHealth Care
Address:
City:
Waukesha
Zip:
53188
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
262-928-5539
Email:
Chanda.miller@phci.org
Investigator:
Last name:
Timothy R. Wassenaar
Email:
Principal Investigator
Facility:
Name:
Aurora Cancer Care-Milwaukee West
Address:
City:
Wauwatosa
Zip:
53226
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
Aurora West Allis Medical Center
Address:
City:
West Allis
Zip:
53227
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Rebecca E. McFall
Email:
Principal Investigator
Facility:
Name:
University of Alberta Hospital
Address:
City:
Edmonton
Zip:
T6G 2B7
Country:
Canada
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
780-407-8798
Email:
pedsoncologyresearch@ahs.ca
Investigator:
Last name:
Sarah J. McKillop
Email:
Principal Investigator
Facility:
Name:
CancerCare Manitoba
Address:
City:
Winnipeg
Zip:
R3E 0V9
Country:
Canada
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
866-561-1026
Email:
ctu_web@cancercare.mb.ca
Investigator:
Last name:
Ashley Chopek
Email:
Principal Investigator
Facility:
Name:
IWK Health Centre
Address:
City:
Halifax
Zip:
B3K 6R8
Country:
Canada
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
902-470-8520
Email:
Research@iwk.nshealth.ca
Investigator:
Last name:
Craig Erker
Email:
Principal Investigator
Facility:
Name:
Children's Hospital
Address:
City:
London
Zip:
N6A 5W9
Country:
Canada
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
519-685-8306
Investigator:
Last name:
Shayna M. Zelcer
Email:
Principal Investigator
Facility:
Name:
Children's Hospital of Eastern Ontario
Address:
City:
Ottawa
Zip:
K1H 8L1
Country:
Canada
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
613-737-7600
Investigator:
Last name:
Donna L. Johnston
Email:
Principal Investigator
Facility:
Name:
Hospital for Sick Children
Address:
City:
Toronto
Zip:
M5G 1X8
Country:
Canada
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
416-813-7654
Email:
ask.CRS@sickkids.ca
Investigator:
Last name:
Angela S. Punnett
Email:
Principal Investigator
Facility:
Name:
The Montreal Children's Hospital of the MUHC
Address:
City:
Montreal
Zip:
H3H 1P3
Country:
Canada
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
514-412-4445
Email:
info@thechildren.com
Investigator:
Last name:
Stephanie Mourad
Email:
Principal Investigator
Facility:
Name:
Centre Hospitalier Universitaire Sainte-Justine
Address:
City:
Montreal
Zip:
H3T 1C5
Country:
Canada
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
514-345-4931
Email:
yvan.samson@umontreal.ca
Investigator:
Last name:
Monia Marzouki
Email:
Principal Investigator
Facility:
Name:
Centre Hospitalier Universitaire de Sherbrooke-Fleurimont
Address:
City:
Sherbrooke
Zip:
J1H 5N4
Country:
Canada
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
819-820-6480
Email:
crcinformation.chus@ssss.gouv.qc.ca
Investigator:
Last name:
Josee Brossard
Email:
Principal Investigator
Facility:
Name:
CHU de Quebec-Centre Hospitalier de l'Universite Laval (CHUL)
Address:
City:
Quebec
Zip:
G1V 4G2
Country:
Canada
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
418-525-4444
Email:
rechclinique@crchudequebec.ulaval.ca
Investigator:
Last name:
Bruno Michon
Email:
Principal Investigator
Facility:
Name:
University Pediatric Hospital
Address:
City:
San Juan
Zip:
00926
Country:
Puerto Rico
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
787-474-0333
Investigator:
Last name:
Maria E. Echevarria
Email:
Principal Investigator
Start date:
May 11, 2023
Completion date:
April 28, 2031
Lead sponsor:
Agency:
National Cancer Institute (NCI)
Agency class:
NIH
Source:
National Cancer Institute (NCI)
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05675410
